We are live on
!
Find out more
SA
Sicart Associates Portfolio holdings
AUM
$389M
1-Year Est. Return
42.46%
This Fund
S&P 500
This Quarter
Est. Return
+4.46%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$145M
AUM Growth
–
Cap. Flow
+$140M
Cap. Flow
% of AUM
96.74%
Top 10 Holdings %
Top 10 Hldgs %
37.51%
Holding
100
New
100
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$11.1M |
| 2 |
SPDR Gold Trust
GLD
|
+$6.86M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$5.37M |
| 4 |
POT
Potash Corp Of Saskatchewan
POT
|
+$4.54M |
| 5 |
PTC Therapeutics
PTCT
|
+$4.52M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.27% |
| 2 | Technology | 17.32% |
| 3 | Energy | 16.51% |
| 4 | Industrials | 11.97% |
| 5 | Materials | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ionis Pharmaceuticals
IONS
$8.6B
| $13.4M | 9.25% |
+280,315
| New | +$11.1M |
|
|
2
SPDR Gold Trust
GLD
$131B
| $6.48M | 4.47% |
+59,113
| New | +$6.86M |
|
|
PXD
3
DELISTED
Pioneer Natural Resource Co.
PXD
| $5.28M | 3.64% |
+29,300
| New | +$5.37M |
|
|
POT
4
DELISTED
Potash Corp Of Saskatchewan
POT
| $4.74M | 3.27% |
+261,775
| New | +$4.54M |
|
|
5
PTC Therapeutics
PTCT
$5.68B
| $4.7M | 3.25% |
+431,135
| New | +$4.52M |
|
|
UTEK
6
DELISTED
Ultratech Inc.
UTEK
| $4.61M | 3.18% |
+192,035
| New | +$4.38M |
|
|
MBLY
7
DELISTED
Mobileye N.V.
MBLY
| $4.03M | 2.78% |
+105,807
| New | +$3.98M |
|
8
APA Corp
APA
$13.2B
| $3.83M | 2.64% |
+60,295
| New | +$3.8M |
|
9
Patterson-UTI
PTEN
$3.98B
| $3.71M | 2.56% |
+137,775
| New | +$3.4M |
|
10
SLB Ltd
SLB
$73.6B
| $3.56M | 2.46% |
+42,400
| New | +$3.48M |
|
11
Microsoft
MSFT
$3.45T
| $3.51M | 2.42% |
+56,536
| New | +$3.4M |
|
12
OraSure Technologies
OSUR
$279M
| $3.24M | 2.24% |
+369,049
| New | +$3.05M |
|
13
Corning
GLW
$119B
| $3.12M | 2.15% |
+128,525
| New | +$3.05M |
|
14
Apple
AAPL
$4.54T
| $2.88M | 1.98% |
+99,280
| New | +$2.81M |
|
15
Clean Harbors
CLH
$16.5B
| $2.49M | 1.72% |
+44,775
| New | +$2.26M |
|
16
Pfizer
PFE
$143B
| $2.46M | 1.7% |
+79,983
| New | +$2.44M |
|
17
Weyerhaeuser
WY
$18B
| $2.28M | 1.58% |
+75,900
| New | +$2.34M |
|
18
Alphabet (Google) Class C
GOOG
$4.36T
| $2.24M | 1.55% |
+58,120
| New | +$2.26M |
|
19
Targa Resources
TRGP
$58B
| $2.24M | 1.55% |
+40,000
| New | +$2.02M |
|
20
Johnson Controls International
JCI
$88.8B
| $2.15M | 1.49% |
+52,262
| New | +$2.29M |
|
21
Marathon Petroleum
MPC
$92.4B
| $2.12M | 1.46% |
+42,000
| New | +$1.91M |
|
|
AIRM
22
DELISTED
Air Methods Corp
AIRM
| $2.1M | 1.45% |
+65,888
| New | +$2.03M |
|
|
AGN
23
DELISTED
Allergan plc
AGN
| $2.09M | 1.44% |
+9,944
| New | +$2.06M |
|
24
Merck
MRK
$322B
| $2.05M | 1.41% |
+36,478
| New | +$2.13M |
|
25
Biogen
BIIB
$30B
| $1.93M | 1.33% |
+6,800
| New | +$2.02M |
|
Similar funds
AIM
WCM
HP
P8IP
PFPGI
PG
S
LHC
Sicart Associates's Q4 2016 Portfolio in Review
Q4 2016 is the first quarter with a 13F filing on record for Sicart Associates, which disclosed 100 positions worth $145M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Ionis Pharmaceuticals: 280,315 shares worth $13.4M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Technology and Energy.
- Sicart Associates's largest Q4 2016 buy was Ionis Pharmaceuticals: 280,315 shares worth $13.4M.
- Sicart Associates's ten largest holdings make up 38% of its $145M portfolio in Q4 2016.
- Sicart Associates disclosed 100 positions in Q4 2016, its first 13F filing on record.
Based on Sicart Associates's 13F filing for Q4 2016, filed 7 Feb 2017.